Clinical Trial Update: Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma

View source ↗

Summary

A clinical trial is investigating the role of RPL8 protein alterations in high-grade serous ovarian cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: High Grade Serous Ovarian Cancer | Status: RECRUITING